The original video was published on Talk Business 360.
Paris, June 2025 Partex has reduced the end-to-end timeline for antibody optimization from > 700 hours to 48 hours – a reduction by 93%. This enables faster, ...
Partnership builds on the successful launch of AK0707 collaboration, advancing next-generation oncology asset through AI-driven life cycle management Frankfur...
Frankfurt, Germany & Miami, FL, USA – March 17, 2025 – Partex NV and Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical compan...
Frankfurt, Germany, 20th February, 2025 – Partex is pleased to announce a strategic collaboration with Princeton Drug Discovery Ltd (PDD), a leading biotech c...
Pune, [13-02-2025]: Pimpri Chinchwad University (PCU) reaffirmed its commitment to technological excellence and academic innovation by organizing a two -day Fac...
Pressemitteilung vom 08.01.2025 Die Amrit AG, ein Unternehmen der Partex Gruppe - einem führenden Anbieter von KI-Lösungen im Gesundheitswesen - gibt heute de...
Partnership aims to expand therapeutic potential of proprietary autotaxin inhibitor through AI-driven approach Frankfurt, Germany – Date – Partex, a leader in ...
Frankfurt, Germany, 3 rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce i...
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce its partnership wi...
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF Lifesciences, an established ...
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read More
